Uli Stilz

Uli Stilz

Company: Novo Nordisk Bio Innovation Hub

Job title: VP


Panel Discussion: The Future of Biologics to Develop Next Generation GPCR-Targeted Therapeutics 9:00 am

Biologics offer great potential in developing therapeutics targeting GPCRs due to their high affinity, selectivity, and long half-life. While many antibodies to GPCRs are in clinical trials and two antibodies have been FDA approved, further effort is needed to promote the rate of advancement of biologics targeting GPCRs. We will discuss the current challenges and…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.